Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the safety of SH T00658ID with regard to plasma
lipids, hemostatic variables, and carbohydrate metabolism. In addition, the pharmacokinetic
parameter following the long term administration of SH T00658ID will be assessed.